Luo J, Zhang H, Bu C, Zhang M, Liu Q, Wang J
Quant Imaging Med Surg. 2025; 15(1):1080-1084.
PMID: 39838976
PMC: 11744115.
DOI: 10.21037/qims-24-1391.
Gu X, Wei S, Lv X
Signal Transduct Target Ther. 2024; 9(1):226.
PMID: 39218931
PMC: 11366768.
DOI: 10.1038/s41392-024-01938-6.
Ciccioli M, Kim K, Khazan N, Khoury J, Cooke M, Miller M
J Exp Clin Cancer Res. 2024; 43(1):240.
PMID: 39169412
PMC: 11337573.
DOI: 10.1186/s13046-024-03149-x.
Kouhmareh K, Martin E, Finlay D, Bhadada A, Hernandez-Vargas H, Downey F
PLoS One. 2024; 19(7):e0306450.
PMID: 39083508
PMC: 11290651.
DOI: 10.1371/journal.pone.0306450.
Sayed Z, Khattap M, Madkour M, Yasen N, Elbary H, Elsayed R
Discov Oncol. 2024; 15(1):94.
PMID: 38557916
PMC: 10984915.
DOI: 10.1007/s12672-024-00949-7.
Tumor heterogeneity and clinically invisible micrometastases in metastatic breast cancer-a call for enhanced surveillance strategies.
Bacon E, Ihle K, Guo W, Egelston C, Simons D, Wei C
NPJ Precis Oncol. 2024; 8(1):81.
PMID: 38553598
PMC: 10980766.
DOI: 10.1038/s41698-024-00572-3.
Breast Tumor Metastasis and Its Microenvironment: It Takes Both Seed and Soil to Grow a Tumor and Target It for Treatment.
Bonni S, Brindley D, Chamberlain M, Daneshvar-Baghbadorani N, Freywald A, Hemmings D
Cancers (Basel). 2024; 16(5).
PMID: 38473273
PMC: 10931297.
DOI: 10.3390/cancers16050911.
Key processes in tumor metastasis and therapeutic strategies with nanocarriers: a review.
Li H, Huang H, Tan H, Jia Q, Song W, Zhang Q
Mol Biol Rep. 2024; 51(1):197.
PMID: 38270746
DOI: 10.1007/s11033-023-08910-7.
Exploring Biomarkers in Breast Cancer: Hallmarks of Diagnosis, Treatment, and Follow-Up in Clinical Practice.
Lopez-Gonzalez L, Cendra A, Cendra C, Cervantes E, Espinosa J, Pekarek T
Medicina (Kaunas). 2024; 60(1).
PMID: 38256428
PMC: 10819101.
DOI: 10.3390/medicina60010168.
Isolation and Genomic Analysis of Circulating Tumor Cell Clusters in Cancer Patients.
Reduzzi C, Vismara M, Schamberger T, Silvestri M, Motta R, Polzer B
Methods Mol Biol. 2024; 2752:101-117.
PMID: 38194030
DOI: 10.1007/978-1-0716-3621-3_7.
Development and validation of a circulating tumor cells-related signature focusing on biochemical recurrence and immunotherapy response in prostate cancer.
Zhang X, Hong B, Sun Z, Zhao J, Li M, Wei D
Heliyon. 2023; 9(12):e22648.
PMID: 38107322
PMC: 10724679.
DOI: 10.1016/j.heliyon.2023.e22648.
Factors influencing the diagnostic and prognostic values of circulating tumor cells in breast cancer: a meta-analysis of 8,935 patients.
Zhao H, Wang L, Fang C, Li C, Zhang L
Front Oncol. 2023; 13:1272788.
PMID: 38090481
PMC: 10711619.
DOI: 10.3389/fonc.2023.1272788.
Single-cell analysis technologies for cancer research: from tumor-specific single cell discovery to cancer therapy.
Chen S, Jiang W, Du Y, Yang M, Pan Y, Li H
Front Genet. 2023; 14:1276959.
PMID: 37900181
PMC: 10602688.
DOI: 10.3389/fgene.2023.1276959.
Capture of circulating metastatic cancer cell clusters from a lung cancer patient can reveal a unique genomic profile and potential anti-metastatic molecular targets: A proof of concept study.
Kouhmareh K, Martin E, Finlay D, Bhadada A, Hernandez-Vargas H, Downey F
bioRxiv. 2023; .
PMID: 37781582
PMC: 10541091.
DOI: 10.1101/2023.09.19.558270.
New advances in circulating tumor cell‑mediated metastasis of breast cancer (Review).
Zhou J, Liu Z, Chen Y, Liu Y, Shen H, Hou L
Mol Clin Oncol. 2023; 19(3):71.
PMID: 37614367
PMC: 10442766.
DOI: 10.3892/mco.2023.2667.
Association of Circulating Tumor Cells, Megakaryocytes and a High Immune-Inflammatory Environment in Metastatic Breast Cancer.
Grasic Kuhar C, Silvester J, Mencinger M, Ovcaricek T, Cemazar M, Miceska S
Cancers (Basel). 2023; 15(13).
PMID: 37444507
PMC: 10340574.
DOI: 10.3390/cancers15133397.
Clinical Significance of PD-L1 Status in Circulating Tumor Cells for Cancer Management during Immunotherapy.
Strati A, Economopoulou P, Lianidou E, Psyrri A
Biomedicines. 2023; 11(6).
PMID: 37371863
PMC: 10296703.
DOI: 10.3390/biomedicines11061768.
Exploring the Potential Driver Gene Mutations That Promote Renal Cancer Cell Metastasis and Implantation Based on Circulating Tumor Cells Culture.
Hong B, Zhang X, Du X, Yang D, Hu Z, Zhang X
Diagnostics (Basel). 2023; 13(11).
PMID: 37296706
PMC: 10252915.
DOI: 10.3390/diagnostics13111855.
Correlation between the expression of CD24 on circulating tumor cells and prognosis in breast cancer.
Zhou M, Xie P, Chen L, Zhang P, Xu F
Am J Transl Res. 2023; 15(3):1941-1952.
PMID: 37056857
PMC: 10086875.
Liquid Biopsy in the Management of Breast Cancer Patients: Where Are We Now and Where Are We Going.
Mazzitelli C, Santini D, Corradini A, Zamagni C, Trere D, Montanaro L
Diagnostics (Basel). 2023; 13(7).
PMID: 37046459
PMC: 10092978.
DOI: 10.3390/diagnostics13071241.